DERMATOMYOSITIS (DM)
Clinical trials for DERMATOMYOSITIS (DM) explained in plain language.
Never miss a new study
Get alerted when new DERMATOMYOSITIS (DM) trials appear
Sign up with your email to follow new studies for DERMATOMYOSITIS (DM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets immune diseases in early trial
Disease control Recruiting nowThis early-stage study tests a new drug called RAY121 in people with six different immune system diseases, including antiphospholipid syndrome and bullous pemphigoid. The main goal is to check safety and how the body processes the drug. About 144 adults will take part to see if t…
Matched conditions: DERMATOMYOSITIS (DM)
Phase: PHASE1 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated May 17, 2026 10:04 UTC
-
Fish oil fights rare muscle disease: new trial launches
Disease control Recruiting nowThis study tests whether omega-3 fatty acid supplements from fish oil can reduce disease activity in adults with dermatomyositis, a rare autoimmune condition causing muscle weakness and skin rashes. About 300 participants will take either omega-3 capsules or a placebo for 6 month…
Matched conditions: DERMATOMYOSITIS (DM)
Phase: PHASE2 • Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Disease control
Last updated May 13, 2026 16:03 UTC